Concepedia
3
Publications
148
Citations
H-Index
1995
Active since
Affiliations
Pfizer (United States)(Current)
KEIJI KANEDA is an author at Pfizer (United States).
Publications per year
1995–1998
CJ-12,371 and CJ-12,372, Two Novel DNA Gyrase Inhibitors. Fermentation, Isolation, Structural Elucidation and Biological Activities.
Shinichi Sakemi, TAISUKE INAGAKI, KEIJI KANEDA et al. · The Journal of Antibiotics · 1995 · 58 citations · Full text
CJ-12,954 and Its Congeners, New Anti-Helicobacter pylori Compounds Produced by Phanerochaete velutina:Fermentation, Isolation, Structural Elucidation and Biological Activities.
Koen Dekker, TAISUKE INAGAKI, Thomas D. Gootz et al. · The Journal of Antibiotics · 1997 · 58 citations · Full text
CJ-12,373, a Novel Topoisomerase II Inhibitor: Fermentation, Isolation, Structure Elucidation and Biological Activities.
TAISUKE INAGAKI, KEIJI KANEDA, Yumiko Suzuki et al. · The Journal of Antibiotics · 1998 · 32 citations
Rows per page
1–3 of 3